TNFRSF11B and postmenopausal osteoporosis: In the development of osteoporosis, an increased concentration of sclerostin and DKK-1 reduces the differentiation rate and activity of osteoblasts through the WNT pathway inhibition and results, for example, in reduced β-catenin and OPG levels in patients with postmenopausal osteoporosis [56].